Lupin receives approval from USFDA for Fesoterodine Fumarate Extended-Release Tablets
Fesoterodine Fumarate Extended-Release Tablets, 4 mg and 8 mg, (RLD Toviaz®) had estimated annual sales of USD 177 million in the U.S. (IQVIA MAT September 2022).
Fesoterodine Fumarate Extended-Release Tablets, 4 mg and 8 mg, (RLD Toviaz®) had estimated annual sales of USD 177 million in the U.S. (IQVIA MAT September 2022).
Partnership to leverage the Helix Laboratory Platform and QIAGEN's biopharma relationships, NGS capabilities, and global regulatory expertise
Passengers arriving from 6 high-risk countries are now mandatorily required to upload their negative RT-PCR test
Triazolam tablets are used on a short-term basis to treat insomnia (difficulty falling asleep or staying asleep)
All claims against the company in the litigation have now been dismissed.
The current approval is first of the many fillings made by the company's CDMO partners from the flagship facility in Bangalore
Centre and states need to work in tandem and in a collaborative spirit as was done during the previous surges for COVID-19 prevention and management
Selexipag tablet is indicated in adults for the treatment of pulmonary arterial hypertension to delay disease progression and reduce the risk of hospitalization for PAH
According to IQVIA sales data for the 12-month period ending October 2022, the Cardene Capsules, 20 mg and 30 mg market achieved annual sales of approximately US $10.9 million
Subscribe To Our Newsletter & Stay Updated